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Abstract: Ovarian cancer has the highest mortality rate of all gynecological malignancies and the
five-year death rate of patients has remained high in the past five decades. Recently, with the rise
of cancer stem cells (CSCs) theory, an increasing amount of research has suggested that CSCs give
rise to tumor recurrence and metastasis. Theasaponin E1 (TSE1 ), which was isolated from green
tea (Camellia sinensis) seeds, has been proposed to be an effective compound for tumor treatment.
However, studies on whether TSE1 takes effect through CSCs have rarely been reported. In this
paper, ALDH-positive (ALDH+) ovarian cancer stem-like cells from two platinum-resistant ovarian
cancer cell lines A2780/CP70 and OVCAR-3 were used to study the anti-proliferation effect of TSE1
on CSCs. The ALDH+ cells showed significantly stronger sphere forming vitality and stronger cell
migration capability. In addition, the stemness marker proteins CD44, Oct-4, Nanog, as well as
Bcl-2 and MMP-9 expression levels of ALDH+ cells were upregulated compared with the original
tumor cells, indicating that they have certain stem cell characteristics. At the same time, the results
showed that TSE1 could inhibit cell proliferation and suspension sphere formation in ALDH+ cells.
Our data suggests that TSE1 as a natural compound has the potential to reduce human ovarian
cancer mortality. However, more research is still needed to find out the molecular mechanism of
TSE1 -mediated inhibition of ALDH+ cells and possible drug applications on the disease.
Keywords: theasaponin E1 ; Camellia sinensis; cancer stem cells; ALDH; ovarian cancer

1. Introduction
Ovarian cancer has the highest mortality rate of all gynecological malignancies [1], resulting in
approximately 22,280 new cases being diagnosed and 14,240 deaths occuring every year in the United
States [2]. Around 70% patients fall into relapse and experience chemo-resistance, and the five-year
survival rate remains less than 40% [3]. Recently, with the rise of cancer stem cell (CSCs) theory,
increasingly more research results have shown that CSCs have typical stem cell characteristics,
such as self-renewal, multidifferentiation, and tumorigenicity etc., [4]. CSCs have been confirmed
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and isolated in various solid tumors, such as breast cancer [5], ovarian cancer [6], pancreas cancer [7],
colon cancer [8] and acute myeloid leukemia [9]. Meanwhile, increasingly more studies have suggested
that CSCs contribute to tumor growth, metastasis, chemo-resistance and recurrence with the neoplasm
renewal source. In addition, the existence of CSCs is also a key reason for the failure of conventional
tumor treatments [10]. Thus far, the biomakers including CD44, CD133, CD117, CD24 and aldehyde
dehydrogenase (ALDH) have been extensively studied to differentiate and identify CSCs [1,6].
Among these, studies suggest that ALDH may be involved in the epithelial-mesenchymal transition of
tumor cells, allowing cancer cells to evade T-cell-mediated cytolysis, and contributing to the oxidation
of retinol to retinoic acid in early stem cell differentiation [11]. At present, ALDH+ cells exhibited
tumorigenic and chemo-resistance capacity, and proved to be associated with poor patient outcome in
high-grade serous ovarian cancer [6].
Selectively targeting CSCs is a new strategy for tumor treatment. At the same time,
natural compounds have received increasing attention in the research of cancer and CSCs due to
their high activity and low number of side effects. The saponins from Rhizoma paridis have shown
the inhibitory effect on growth of CSCs in non-small cell lung cancer [12]. EGCG and TFs can inhibit
the self-renewal capacity of prostate CSCs, in part by downregulating Bmi1 gene expression [13].
Theasaponin E1 (TSE1 ), an acylated oleanene-type triterpene ologoglycoside with the molecular
formula C59 H90 O27 , was firstly isolated from green tea [Camellia sinensis (L.) O. Kuntze] seeds in
1998 [14]. This compound has been proven to possess various activities. TSE1 could alleviate the salt
tolerance of yeasts [15], and inhibit ethanol-induced gastric mucosal lesions [16], angiogenesis and
obesity [17]. It could also suppress the human tumor cell lines K562 and HL60 [18]. Our previous
study showed that the total saponins from C. sinensis seeds exhibit potent growth inhibitory effect on
two cisplatin-resistant ovarian cancer cell lines A2780/CP70 and OVCAR-3 [19].
In this study, A2780/CP70 and OVCAR-3 cell lines were chosen. The tumor sphere culture
method was selected to accumulate CSCs. ALDH was used as a stem cell surface marker to indirectly
detect the proportion of CSCs. TSE1 was selected as the experimental drug. The purpose is to detect
the population of ALDH+ cells that were accumulated in two ovarian cancer cell lines and determine if
those cells have certain stem cell characteristics, then investigate the effect of TSE1 on the ALDH+ cells.
2. Results
2.1. Expression of ALDH in Both Tumor and Sphere Cells
According to the basic principle of serum-free culture, the differentiated mature tumor cells cannot
adhere to the wall and go to apoptosis in the serum-free state, whereas undifferentiated CSCs within
total tumor cells can grow and experience multidifferentiation into both tumor and CSCs to form
a spherical aggregate state, thus differentiating from each other. The spheres derived from A2780/CP70
and OVCAR-3 cells appeared and completely formed within seven days (one week). It can be seen in
Figure 1a that two ovarian cancer cells exhibit spindle or oval-shaped single cell distribution in the
adherent culture, but, in the serum-free culture state, both cells showed different degrees of spherical
dense multicellular aggregation and were able to float in the culture fluid. The results indicated the
presence of CSCs in both ovarian cancer cells. An ALDEFLUOR Stem Cell Identification Kit was used
to examine the proportion of ALDH+ cells in the tumor and different culture algebraic suspension cells.
The experimental results showed (Figure 1b) that ALDH+ cells ratio was 1.05%, 5.75%, 12.20% and
29.50% in tumor cells and sphere cells with 1-week, 2-weeks and 3-weeks in A2780/CP70, and 1.25%,
2.75%, 7.20%, 24.95% in OVCAR-3, respectively. Our results indicated that there was indeed a very
small amount of ALDH+ cells in both ovarian cancer cells, which was less than 2.0%, while the
proportion of ALDH+ cells in two cell lines showed a significant increase trend in a time-dependent
manner. In addition, the increasing trend of the A2780/CP70 cell line and the proportion of ALDH+
cells were higher than that of OVCAR-3. The proportion of ALDH+ cells in both of the suspension
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Figure 1. The population of ALDH of both tumor and sphere cells cultured in serum-free medium

Figure 1. The population of ALDH of both tumor and sphere cells cultured in serum-free medium
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environment in the harsh environment of dense spherical cells in the absence of oxygen and nutrient
delivery. To confirm whether ALDH+ cells have a stronger ability to metastasize and invade, we
conducted Transwell chamber experiments and screened ALDH+ cells (three generation) as followup study subjects. The above results demonstrated that ALDH+ cells, especially third-generation cells,
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Figure 3. Sphere cells (3-weeks) from A2780/CP70 and OVCAR-3 cell lines possess the stemness
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Taken together, our findings indicated that ALDH+ cells (3-weeks) accumulated with serumfree culture have certain biological characteristics of CSCs, and can be considered as ovarian cancer
stem-like cells for follow-up experiments.
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concentration, the inhibitory activity of TSE1 on ALDH+ cells was significantly increased, and the
action time had a certain enhancement effect. When the concentration reached to 40 µM, prolonging
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the action time can significantly enhance the inhibitory effect of TSE 1. The overall detection analysis
was consistent with the observed cell morphology results. It was complemented that TSE 1 could
inhibit ALDH+ cells in a dose-dependent manner. The action time could enhance this inhibition to a
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2.4. TSE1 Suppresses the Sphere Formation of Sphere Cells
In view of the MTS results, the ability of TSE1 to inhibit the proliferation of ALDH+ cells was
achieved by inhibiting the size and number of the cell spheres. We further investigated whether TSE1
affects the ability of CSCs single cell to pellet. Figure 6 showed that TSE1 exhibited a similar trend
for ALDH+ cells in two cell lines. At low concentrations of 5 µM and 10 µM TSE1 , the number of
single cells pelleted was not significantly different from that of the control group even when the action
time was extended from 24 h to 72 h, indicating that low concentration had no effect on the single cell
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3. Discussion
Accumulating evidence has proposed that CSCs play a key role in driving and sustaining tumor
initiation, progression and malignant proliferation; CSCs were therefore believed to be the key target
for prevention of tumor recurrence and metastasis [2,4]. Thus, target therapy for CSCs attracts more
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protein levels of CD44, Nanog and Oct-4 observed in this study were inconsistent with the previous
reports, indicating that the ALDH+ cells had some stemness properties. Moreover, antiapoptotic
factor Bcl-2 and the migration related protein MMP-9 were significantly increased in ALDH+ cells
compared with ALDH− tumor cells. Researchers have demonstrated that the Bcl-2 protein family
plays an essential role in regulating intrinsic or mitochondrial apoptosis, and is strongly associated
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ovarian cancer [6]. Higher protein levels of CD44, Nanog and Oct-4 observed in this study were
inconsistent with the previous reports, indicating that the ALDH+ cells had some stemness properties.
Moreover, antiapoptotic factor Bcl-2 and the migration related protein MMP-9 were significantly
increased in ALDH+ cells compared with ALDH− tumor cells. Researchers have demonstrated that
the Bcl-2 protein family plays an essential role in regulating intrinsic or mitochondrial apoptosis, and
is strongly associated with drug resistance [25]. Over-expression of Bcl-2 protein has been observed
in side population cells from high grade ovarian cancer [26]. In addition, MMP-9 plays an important
role in the cell metastasis and invasion [27] and contributes to the ovarian tumor aggression and
recurrence [22,28]. The observed over-expressed stemness markers could explain the significantly
enhanced migration activity of ALDH+ cells from both the cell lines and the increased invasion
ability of A2780/CP70 cell line. Overall, our data suggested that ALDH+ cells possessed some cancer
stem cell-like properties including enhanced sphere formation, stronger migration ability and higher
expression of stemness markers.
The saponins have been found to have numerous pharmacological effects including anti-fungal [29],
anti-viral [30], anti-inflammatory [31], anti-hyperlipidemic [32], immunomodulatory [33] and
anti-tumor activities [17,19]. Among these, TSE1 was proved to have higher bioactivity than other
saponin monomers present in tea seeds [17]. Researchers have shown that TSE1 expressed an inhibitory
effect on ethanol-induced gastric mucosal lesions at a dose of 5.0 mg/kg [16]. TSE1 showed significant
quinone reductase (QR) inducing activity at 4 µg/mL (3.25 µM) and could be used as an anti-tumor
agent and a chemo-prevention agent of cancer [18]. Treating with a 10 µg/mL (8.13 µM) concentration
of TSE1 completely inhibited tube formation in human umbilical vein endothelial cells, as well as
TSE1 showing toxicity toward cancer cells and inhibiting in vivo growth of the tumor [17]. On the
other hand, we carried out another study before this work, data showed the estimated half-maximal
inhibitory concentration (IC50 ) of TSE1 for A2780/CP70 and OVCAR-3 tumor cells were 3.46 µM
and 3.28 µM, respectively. Our results were consistent with those reported data. While the IC50
value of TSE1 for normal ovarian surface epithelial cell line IOSE-364 was 23.82 µM, TSE1 showed
a much lower cytotoxic effect against normal ovarian epithelial cells. In addition, our published data
showed that the IC50 values of cisplatin, which is the most effective and widely used chemotherapeutic
agent, were 11.91 µg/mL (35.71 µM) for A2780/CP70 and 10.10 µg/mL (30.30 µM) for OVCAR-3,
respectively [19]. All data taken together, we indicated that TSE1 exhibited higher inhibitory effects
compared to cisplatin. However, few reports have been published to identify the beneficial biological
activities of TSE1 on CSCs. In this study, we used ALDH+ cells with stemness properties as CSCs model
to demonstrate the TSE1 -mediated suppression on CSCs growth and sphere formation. Our results
indicated that TSE1 had significant inhibitory activity against ALDH+ cells of A2780/CP70 and
OVCAR-3 cell lines at concentrations of 20 and 40 µM, but exhibited little influence on both cell lines
at lower concentrations of 5 or 10 µM. The present work indicated that higher TSE1 concentration was
needed to inhibit ALDH+ cells with chemo-resistance capacity [6]. TSE1 decreased numbers of spheres
and cell viability at higher concentrations. As reported, side population cells from high grade ovarian
cancer showed high resistance to chemotherapy drugs, and high survival rate and high potential
to form tumor spheres [26]. The inhibitory effects of TSE1 on cell proliferation and sphere-forming
viability has certain significance to suppress cancer stem cells. However, while increasing TSE1
concentrations impacted the results, increasing the treatment times did not have significant effects.
These results coincide with previous research showing that the cytotoxic effects of saponins on
various cancer cell lines varied based on the type of cell line and on the concentration of saponins [34].
This research also added other evidence to previous research, which demonstrates the anti-proliferative,
anti-tumor and cytotoxic effects of TSE1 [17,18]. These results suggest that TSE1 is a natural and potent
drug candidate for ovarian cancer treatment. However, the molecular weight of tea saponin is 1230,
which is much higher than cisplatin (the molecular weight is 300). Thus, the measurement of the
bioavailability of TSE1 is very valuable for anti-tumor research and possible drug applications for the
disease, as well as the molecular mechanism of TSE1 -mediated inhibition of ALDH+ cells.
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4. Materials and Methods
4.1. General Experimental Procedures
TSE1 (Figure 7) was purchased from Yingshili Biotechnology (Hangzhou, Zhejiang, China),
and was dissolved in dimethyl sulfoxide (DMSO) at 100 mM and stored at −20 ◦ C PLT, 6-well
plates, 24-well plates, 96-well plates, Transwell chambers and Corning Matrigel Basement Membrane
Matrix High Concentration were from Corning (Corning, NY, USA). Aqueous One Solution Cell
Proliferation assay (MTS) was purchased from Promega Corporation (Madison, WI, USA). RPMI-1640
medium was purchased from Sigma-Aldrich (St. Louis, MO, USA). Fetal bovine serum (FBS) was from
Invitrogen
(Grand
Island,
USA). ALDEFLUOR Stem Cell Identification Kit, MammoCult Medium
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4.3. Tumor Sphere Culture
4.3. Tumor Sphere Culture
This progress was performed under serum-free medium and ultra-low adherent conditions
This progress was performed under serum-free medium and ultra-low adherent conditions
according to the manufacturer’s instructions. Briefly, both A2780/CP70 and OVCAR-3 ovarian cancer
according to the manufacturer’s instructions. Briefly, both A2780/CP70 and OVCAR-3 ovarian cancer
cells (tumor cells) were collected when 70% density was achieved and then suspended into the complete
cells (tumor cells) were collected when 70% density was achieved and then suspended into the
mammoculTM mediumTM(complete medium below) supplemented with 4 µg/mL (final concentration)
complete mammocul medium (complete medium below) supplemented with 4 μg/mL (final
0.2% Heparin Sodium Salt and 0.48 µg/mL (final concentration) Hydrocortisone Stock Solution.
concentration) 0.2% Heparin Sodium Salt and 0.48 μg/mL (final concentration) Hydrocortisone Stock
Cells were seeded at a density of 6,000 cells/well in 6-well ultra-low attachment plates, then cultured
Solution. Cells were seeded at a density of 6,000 cells/well in 6-well ultra-low attachment plates, then
for 7 days at 37 ◦ C in a humidified incubator with 5% CO2 , and visualized under a light microscope
cultured for 7 days at 37 °C in a humidified incubator with 5% CO2, and visualized under a light
every day. The spheres were harvested after 7 days of culture for subsequent tumor sphere culture
microscope every day. The spheres were harvested after 7 days of culture for subsequent tumor
using the same method described, and subsequent assays.
sphere culture using the same method described, and subsequent assays.
4.4. ALDEFLUORTM Kit ALDH Analysis
The population of ALDH in tumor and sphere cells (1-week, 2-weeks and 3-weeks) were
analyzed by a ALDEFLUOR Stem Cell Identification Kit according to the manufacturer’s instructions.
All cells were harvested from dishes with Trypsin-EDTA, then suspended using ALDEFLUORTM
Assay Buffer to prepare samples with a density of 106 cells/mL. Then, 1 mL sample was added into a
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4.4. ALDEFLUORTM Kit ALDH Analysis
The population of ALDH in tumor and sphere cells (1-week, 2-weeks and 3-weeks) were analyzed
by a ALDEFLUOR Stem Cell Identification Kit according to the manufacturer’s instructions. All cells
were harvested from dishes with Trypsin-EDTA, then suspended using ALDEFLUORTM Assay
Buffer to prepare samples with a density of 106 cells/mL. Then, 1 mL sample was added into a test
tube with 5 µL activated ALDEFLUORTM Reagent and mixed rapidly. Next, 0.5 mL mixture was
transferred to the control tube with an added 5 µL ALDEFLUORTM DEAB Reagent prior. All test
and control samples were mixed quickly, and then cultured for 45 min at 37 ◦ C in a humidified
atmosphere. Then, all samples were centrifuged at 250× g for 5 min at 4 ◦ C and suspended in 0.5 mL
ALDEFLUORTM assay buffer. All samples were stored on ice before detection. Finally, all samples
were filtered through a 40 µm cell trainer to obtain single suspension cells for analysis on a FACSAria
III Flow cytometer (BD).
4.5. Sphere Formation Assay
Tumor and sphere cells (1-week, 2-weeks and 3-weeks) were harvested, then lightly centrifuged at
250× g for 5 min at room temperature, and resuspended using complete medium. All cells were plated
at a density of 100 cells/well in 96-well ultra-low adherent plates, and cultured for a subsequent 7 days
in a humidified incubator containing 5% CO2 at 37 ◦ C. The cells were visualized and the number
of spheres (>50 µm) formed were counted [27] under a light microscope every day. All data were
collected from six independent trials to determine the inhibition effect of sphere formation by TSE1 .
Sphere cells (3-weeks) were harvested and seeded under the same condition, and cultured for 24 h.
Then, cells were treated with various concentrations of TSE1 (0 to 40 µg/mL) for 24, 48 and 72 h.
The control group received only an equal amount of complete medium. Then, the number of spheres
was counted as above. All data were collected from five independent experiments
4.6. Western Blot Analysis
Ovarian cancer cells were seeded and incubated overnight until 70% density was achieved.
Sphere cells (3-weeks) were collected after 7 days of culture. All cells were centrifuged at 350× g for
5 min at 4 ◦ C to remove the old medium. After a double wash with cold PBS, cells were lysed in
50 µL M-PER Mammalian Protein Extraction Reagent supplemented with 1 µL HaltTM Protease and
Phosphatas Inhibitor. Total protein levels were determined by a BCA Protein Assay Kit. The cell lysates
were separated by SDS-PAGE and blotted onto a nitrocellulose membrane with a Mini-Protean 3 System
(Bio-Rad, Hercules, CA, USA). Membranes were blocked with 5% non-fat milk (dissolved in Tris-buffer
saline supplemented with 0.1% Tween 20 (TBST)) for 1 h at room temperature. Then, the membranes
were incubated with specific primary antibodies and secondary antibody dilutions. After washing
with TBST in triplicate, the antigen-antibody complex was visualized with ECL Kit. Protein bands
were quantified with NIH Image J software (version, NIH, Bethesda, MD, USA), and normalized by
corresponding GAPDH bands for analysis.
4.7. Transwell Migration and Invasion Assays
In addition, 50 µL 1/8 dilution of matrigel was seeded into upper Transwell chambers and
solidified in a humidified incubator at 37 ◦ C for 30 min to firm membrane for subsequent invasion
assay. Both A2780/CP70 and OVCAR-3 tumor and sphere cells (3-weeks) in suspension serum-free
medium were plated into the upper chambers at 2 × 105 cells/well for invasion assay, and migration
assay without matrigel membrane. A complete medium containing 20% FBS was added to the lower
chamber and incubated for another 24 h. The medium was wiped in the upper chambers and washed
with PBS twice at room temperature. A cotton swab was used to gently wipe out the residual solution
and then crystal violet staining cells were passed through the membrane and attached to the lower
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layer of the membrane for at least 15 min after formaldehyde fixing cells for 15 min. Graphics of cells
that migrated or invaded were taken using wide-field microscopy.
4.8. Cell Viability
Cell growth inhibition was determined by using MTS assay as described as before [19]. Sphere cells
(3-weeks) were seeded into 96-well ultra-low adherent plates at a density of 2000 cells/well in complete
medium for 24 h. Then, cells were treated with various concentrations of TSE1 (0 to 40 µg/mL) for
24, 48 and 72 h at 37 ◦ C in a humidified 5% CO2 incubator. The control group received only an equal
amount of complete medium. Then, morphologic observation for spheres was carried out under a light
microscope before cell viability analysis. For MTS assay, 100 µL of MTS was added to each well and
incubated in the dark at 37 ◦ C for 1 h. The absorbance was measured at 490 nm with a microplate
reader. Cell viability was expressed as the percentage compared to the untreated group. All data was
collected from five independent experiments.
4.9. Statistical Analysis
In this study, the experiments were performed at least three times. Average values of replicates
were collected and analyzed by one-way analysis of variance (ANOVA) in SPSS 23.0 (Manufacturer, City,
US State abbrev. if applicable, Country). Significant differences between individual treatments and control
were evaluated using Duncan’s test. * = p ≤ 0.05 was considered statistically significant.
5. Conclusions
In this work, the data showed that a rare population of CSCs (less than 2.0%) existed in
A2780/cp70 and OVCAR-3 cell lines and CSCs were noticeably accumulated through serum-free
spheroid formation assay. Most importantly, we demonstrated that ALDH+ cells performed stronger
single cell sphering and migration ability, and demonstrated over-expression of stemness marker
proteins CD44, Nanog and Oct-4, and cancer stem cell-associated proteins Bcl-2 and MMP-9,
thus indicating some biological characteristics of cancer stem cells, which can be considered as
ovarian cancer stem-like cells. In addition, we indicated that TSE1 dose-dependently inhibited the
proliferation and single cell sphere formation ability, though it was not significantly changed by action
time. This study provided new evidence for the anti-tumor activity of TSE1 . We suggest that TSE1 has
potential application for use in chemotherapy options to treat advanced ovarian cancer efficiency in
the future. More research should be aimed at the underlying molecular mechanisms of TSE1 -mediated
suppression ability on ALDH+ cells for better utility of natural compound of TSE1 in tumor therapy.
Author Contributions: L.-Y.J., H.-L.X. conceived and designed the experiments and wrote the paper; Y.-Y.T., Y.C.C.,
D.A.S. and B.L. designed and organized the study; C.C. and H.B. performed the experiments for Western blot
assay of the tested materials; Y.C.C., G.O.R., Z.-D.C., B.L., H.B. and C.C. revised the manuscript; and all authors
approved the final version manuscript.
Funding: This research was supported by Technology Project of Zhejiang Province (Grant No. 2018C02012).
This research was supported by NIH grants P20RR016477 from the National Center for Research Resources and
P20GM103434 from the National Institute for General Medical Sciences (NIGMS) awarded to the West Virginia
IDeA Network of Biomedical Research Excellence. This study was also supported by Grant No. P20GM104932
from NIGMS, a component of the National Institutes of Health (NIH) and its contents are solely the responsibility
of the authors and do not necessarily represent the official view of NIGMS or NIH. This study was also supported
by COBRE grant GM102488/RR032138, ARIA S10 grant RR020866, FORTESSA S10 grant OD016165 and INBRE
grant GM103434. This research was also supported by the National Natural Science Foundation of China
(Grant No. 31501474) and the Natural Science Foundation of Zhejiang Province (Grant No. LY15C200007).
Acknowledgments: We thank Chung S. Yang from the Department of Chemical Biology at Rutgers, the State
University of New Jersey for providing help with revising the manuscript. In addition, we thank Kathy Brundage
from the Flow Cytometry Core at the West Virginia University for providing technical help on ALDH analysis.
And we thank Xiao-Gang Xu from Key Laboratory of Geriatrics, Institute of Geriatrics Research, Zhejiang hospital
for providing valuable and useful suggestions to improve the paper. We thank Fang Zhang from LIFS Department,
School of Science, Hong Kong University of Science and Technology for providing help on statistical analysis.
We also thank Lan Xu, my close friend, for her help to polish the English language.

Molecules 2018, 23, 1469

13 of 14

Conflicts of Interest: The authors declare no conflicts of interest.

Abbreviations
ALDH
CSCs
TSE1

Aldehyde dehydrogenase
Cancer stem cells
Theasaponins E1

References
1.

2.
3.

4.
5.

6.
7.
8.
9.
10.
11.

12.
13.
14.

15.
16.

17.
18.

Zhang, R.; Zhang, P.; Wang, H.; Li, W.; Xiao, G.; Li, C. Inhibitory effects of metformin at low concentration on
epithelial–mesenchymal transition of CD44+CD117+ ovarian cancer stem cells. Stem Cell Res. Ther. 2015, 6, 262.
[CrossRef] [PubMed]
Siegel, R.L.; Miller, K.D.; Jemal, A. Cancer statistics, 2016. CA Cancer J. Clin. 2016, 66, 7–30. [CrossRef]
[PubMed]
Baldwin, L.A.; Huang, B.; Miller, R.W.; Tucker, T.; Goodrich, S.T.; Podzielinski, I.; DeSimone, C.P.; Ueland, F.R.;
van Nagell, J.R.; Seamon, L.G. Ten-year relative survival for epithelial ovarian cancer. Obstet. Gynecol.
2012, 120, 612–618. [CrossRef] [PubMed]
Bapat, S.A. Human ovarian cancer stem cells. Reproduction 2010, 140, 33–41. [CrossRef] [PubMed]
Pal, D.; Kolluru, V.; Chandrasekaran, B.; Baby, B.V.; Aman, M.; Suman, S.; Sirimulla, S.; Sanders, M.A.;
Alatassi, H.; Ankem, M.K.; et al. Targeting aberrant expression of Notch-1 in ALDH (+) cancer stem cells in
breast cancer. Mol. Carcinog. 2017, 56, 1127–1136. [CrossRef] [PubMed]
Muinao, T.; Deka Boruah, H.P.; Pal, M. Diagnostic and Prognostic Biomarkers in ovarian cancer and the
potential roles of cancer stem cells-An updated review. Exp. Cell Res. 2018, 362. [CrossRef] [PubMed]
Li, C.; Heidt, D.G.; Dalerba, P.; Burant, C.F.; Zhang, L.; Adsay, V.; Wicha, M.; Clarke, M.F.; Simeone, D.M.
Identification of pancreatic cancer stem cells. Cancer Res. 2007, 67, 1030–1037. [CrossRef] [PubMed]
O’Brien, C.A.; Pollett, A.; Gallinger, S.; Dick, J.E. A human colon cancer cell capable of initiating tumour
growth in immunodeficient mice. Nature 2007, 445, 106–110. [CrossRef] [PubMed]
Bonnet, D.; Dick, J.E. Human acute myeloid leukemia is organized as a hierarchy that originates from
a primitive hematopoietic cell. Nat. Med. 1997, 3, 730–737. [CrossRef] [PubMed]
Hamburger, A.W.; Salmon, S.E. Primary bioassay of human tumor stem cells. Science 1977, 197, 461–463.
[CrossRef] [PubMed]
Ginestier, C.; Hur, M.H.; Charafejauffret, E.; Monville, F.; Dutcher, J.; Brown, M.; Jacquemier, J.; Viens, P.;
Kleer, C.G.; Liu, S.; et al. ALDH1 is a marker of normal and malignant human mammary stem cells and
a predictor of poor clinical outcome. Cell Stem Cell. 2007, 1, 555–567. [CrossRef] [PubMed]
Ng, C.Y.J. To Investigate the Effect of Rhizoma Paridis Saponins on Lung Cancer Stem Cells. Master’s Thesis,
Hong Kong Polytechnic University, Hong Kong, China, 2014.
Zhou, J.R.; Gong, Y. Tea bioactive compounds inhibit prostate cancer stem cells via downregulation of Bmi1.
FASEB J. 2013, 639, 10.
Kitagawa, I.; Hori, K.; Motozawa, T.; Murakami, T.; Yoshikawa, M. Structures of new acylated oleanene-type
triterpene oligoglycosides, theasaponins E1 and E2, from the seeds of tea plant, Camellia sinensis (L.) O.
Kuntze. Chem. Pharm. Bull. (Tokyo) 1998, 46, 1901–1906. [CrossRef] [PubMed]
Tomita, M.; Yamamoto, S.; Yamaguchi, K.; Ohigashi, H.; Yagi, T.; Kohata, K.; Berden, J.A. Theasaponin E1
destroys the salt tolerance of yeasts. J. Biosci. Bioeng. 2000, 90, 637–642. [CrossRef]
Yoshikawa, M.; Morikawa, T.; Li, N.; Nagatomo, A.; Li, X.; Matsuda, H. Bioactive saponins and glycosides.
xxiii. triterpene saponins with gastroprotective effect from the seeds of camellia sinensis–theasaponins E3,
E4, E5, E6, and E7. Chem. Pharm. Bull. (Tokyo) 2005, 53, 1559–1564. [CrossRef] [PubMed]
Kim, J.D.; Chaudhary, N.; Seo, H.J.; Kim, M.Y.; Shin, T.S. Theasaponin E1 as an effective ingredient for
anti-angiogenesis and anti-obesity effects. Biosci. Biotechnol. Biochem. 2014, 78, 279–287. [CrossRef] [PubMed]
Li, N.; Ma, Z.J.; Chu, Y.; Wang, Y.; Li, X. Phytochemical analysis of the triterpenoids with cytotoxicity and
QR inducing properties from the total tea seed saponin of camellia sinensis. Fitoterapia 2013, 84, 321–325.
[CrossRef] [PubMed]

Molecules 2018, 23, 1469

19.

20.

21.
22.
23.
24.
25.
26.
27.
28.

29.
30.
31.

32.

33.

34.

14 of 14

Jia, L.Y.; Wu, X.J.; Gao, Y.; Rankin, G.O.; Pigliacampi, A.; Bucur, H.; Li, B.; Tu, Y.Y.; Chen, Y.C. Inhibitory
effects of total triterpenoid saponins isolated from the seeds of the tea plant (Camellia sinensis) on human
ovarian cancer cells. Molecules 2017, 22, 1649. [CrossRef] [PubMed]
Pals, S.T.; Horst, E.; Ossekoppele, G.J.; Figdor, C.G.; Scheper, R.J.; Meijer, C.J. Expression of lymphocyte
homing receptor as a mechanism of dissemination in non-hodgkin’s lymphoma. Blood 1989, 73, 885–888.
[PubMed]
Sy, M.S.; Guo, Y.J.; Stamenkovic, I. Distinct effects of two CD44 isoforms on tumor growth in vivo. J. Exp. Med.
1991, 174, 859–866. [CrossRef] [PubMed]
Bhattacharya, R.; Mitra, T.; Chaudhuri, S.R.; Roy, S.S. Mesenchymal splice isoform of CD44 (CD44s) promotes
EMT/invasion and imparts stemlike properties to ovarian cancer cells. J. Cell. Biochem. 2017. [CrossRef]
Pesce, M.; Wang, X.; Wolgemuth, D.J.; Schöler, H. Differential expression of the Oct-4 transcription factor
during mouse germ cell differentiation. Mech. Dev. 1998, 71, 89–98. [CrossRef]
Chambers, I.; Colby, D.; Robertson, M.; Nichols, J.; Lee, S.; Tweedie, S.; Smith, A. Functional expression
cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell 2003, 113, 643–655. [CrossRef]
Czabotar, P.E.; Lessene, G.; Strasser, A.; Adams, J.M. Control of apoptosis by the bcl-2 protein family:
Implications for physiology and therapy. Nat. Rev. Mol. Cell Biol. 2014, 15, 49–63. [CrossRef] [PubMed]
Zhang, Q.H.; Dou, H.T.; Xu, P.; Liu, P.S. Tumor recurrence and drug resistance properties of side population
cells in high grade ovary cancer. Drug Res. (Stuttg.) 2015, 65, 153–157. [CrossRef] [PubMed]
Chen, Y.; Jiang, T.; Mao, A.; Xu, J. Esophageal cancer stem cells express plgf to increase cancer invasion
through mmp9 activation. Tumour Biol. 2014, 35, 12749–12755. [CrossRef] [PubMed]
Huang, J.S.; Yao, C.J.; Shuang-En, C.; Chi-Tai, Y.; Liang-Ming, L.; Chen, R.M.; Chao, W.J.; Whang-Peng, J.;
Lai, G.M. Honokiol inhibits sphere formation and xenograft growth of oral cancer side population cells
accompanied with JAK/STAT signaling pathway suppression and apoptosis induction. BMC Cancer
2016, 16, 245. [CrossRef] [PubMed]
Jiang, X.; Feng, K.; Yang, X. In vitro antifungal activity and mechanism of action of tea polyphenols and tea
saponin against rhizopus stolonifer. J. Mol. Microbiol. Biotechnol. 2015, 25, 269–276. [CrossRef] [PubMed]
Hayashi, K.; Sagesaka, Y.M.; Suzuki, T.; Suzuki, Y. Inactivation of human type a and b influenza viruses by
tea-seed saponins. Biosci. Biotechnol. Biochem. 2000, 64, 184–186. [CrossRef] [PubMed]
Yang, W.S.; Ko, J.; Kim, E.; Kim, J.H.; Park, J.G.; Sung, N.Y.; Kim, H.G.; Yang, S.; Rho, H.S.; Hong, Y.D.;
et al. 21-O-Angeloyltheasapogenol E3, a novel triterpenoid saponin from the seeds of tea plants,
inhibits macrophage-mediated inflammatory responses in a NF-κB-dependent manner. Mediators Inflamm.
2014, 2014, 658351. [CrossRef] [PubMed]
Matsuda, H.; Hamao, M.; Nakamura, S.; Kon’I, H.; Murata, M.; Yoshikawa, M. Medicinal flowers. XXXIII.
Anti-hyperlipidemic and anti-hyperglycemic effects of chakasaponinsI-III and structure of chakasaponin
IV from flower buds of Chinese tea plant (Camellia sinensis). Chem. Pharm. Bull. (Tokyo) 2012, 60, 674–680.
[CrossRef] [PubMed]
Bhardwaj, J.; Chaudhary, N.; Seo, H.J.; Kim, M.Y.; Shin, T.S.; Kim, J.D. Immunomodulatory effect of
tea saponin in immune T-cells and T-lymphoma cells viaregulation of Th1, Th2 immune response and
MAPK/ERK2 signaling pathway. Immunopharmacol. Immunotoxicol. 2014, 36, 202–210. [CrossRef] [PubMed]
Joshi, R.; Sood, S.; Dogra, P.; Mahendru, M.; Kumar, D.; Bhangalia, S.; Pal, C.H.; Kumar, N.; Bhushan, S.;
Gulati, A.; et al. In vitro cytotoxicity, antimicrobial, and metal-chelating activity of triterpene saponins from
tea seed grown in kangra valley, india. Med. Chem. Res. 2013, 22, 4030–4038. [CrossRef]

Sample Availability: Not available.
© 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).

